• Join
  • Login
  • Contact

Search abstracts

Challenges and Lessons Learned in the Regulatory Approval Process for Biosimilars

  • In: Biosimilars for all: Research, regulation and responsible use on Thursday, 14 September 2017, 09:00-12:00
  • At: Seoul (South Korea) (2017)
  • Type: Presentation
  • By: SHAH, Vinod (ComCast, ., United States)
  • Co-author(s): Vinod Shah: VPS Consulting, LLC, North Potomax, United States
  • Abstract:

    There are two types of Complex Drug Products: Biological Drug Products and Non-Biological Drug Products (NBCD). The presentation will discuss both, but primarily focus on Biosimilar products. A biosimilar product is a biological product that is highly similar to the reference product not withstanding minor differences in clinically inactive


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses